Nobuhiro Ban
Chugai Pharma (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Cholesterol and Lipid Metabolism, Neonatal Respiratory Health Research, Pancreatic function and diabetes, RNA Interference and Gene Delivery
Most-Cited Works
- → Inhibition of gastric inhibitory polypeptide signaling prevents obesity(2002)943 cited
- → Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice(1999)453 cited
- → Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases(2021)330 cited
- → ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells1(2001)262 cited
- → ABCA3 as a Lipid Transporter in Pulmonary Surfactant Biogenesis(2007)223 cited
- → Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration(2008)155 cited
- → Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency(2006)134 cited
- → Antioxidant α‐tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes(2000)126 cited
- → Hepatocyte Nuclear Factor-1α Recruits the Transcriptional Co-Activator p300 on the GLUT2 Gene Promoter(2002)96 cited
- → Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease(2008)86 cited